355 related articles for article (PubMed ID: 22427353)
21. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
22. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.
Zhao Y; Fu L; Li R; Wang LN; Yang Y; Liu NN; Zhang CM; Wang Y; Liu P; Tu BB; Zhang X; Qiao J
BMC Med; 2012 Nov; 10():153. PubMed ID: 23198915
[TBL] [Abstract][Full Text] [Related]
23. Obesity and insulin resistance increase plasma viscosity in young women with polycystic ovary syndrome.
Vervita V; Saltamavros AD; Adonakis G; Tsapanos V; Decavalas G; Georgopoulos NA
Gynecol Endocrinol; 2009 Oct; 25(10):640-6. PubMed ID: 19557593
[TBL] [Abstract][Full Text] [Related]
24. Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness.
Lystedt E; Westergren H; Brynhildsen J; Lindh-Astrand L; Gustavsson J; Nystrom FH; Hammar M; Strålfors P
Eur J Endocrinol; 2005 Dec; 153(6):831-5. PubMed ID: 16322388
[TBL] [Abstract][Full Text] [Related]
25. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
27. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.
Lewy VD; Danadian K; Witchel SF; Arslanian S
J Pediatr; 2001 Jan; 138(1):38-44. PubMed ID: 11148510
[TBL] [Abstract][Full Text] [Related]
28. Role of Branched-Chain Amino Acids in Metabolic Changes of Polycystic Ovary Syndrome.
Jia FC; Li XL
Obstet Gynecol Surv; 2024 Jun; 79(6):343-347. PubMed ID: 38896430
[TBL] [Abstract][Full Text] [Related]
29. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
[TBL] [Abstract][Full Text] [Related]
30. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
31. The association of the lipidomic profile with features of polycystic ovary syndrome.
Moran LJ; Mundra PA; Teede HJ; Meikle PJ
J Mol Endocrinol; 2017 Jul; 59(1):93-104. PubMed ID: 28500248
[TBL] [Abstract][Full Text] [Related]
32. Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach.
Zhang XJ; Huang LL; Su H; Chen YX; Huang J; He C; Li P; Yang DZ; Wan JB
J Pharm Biomed Anal; 2014 Jul; 95():85-92. PubMed ID: 24637052
[TBL] [Abstract][Full Text] [Related]
33. Cardiometabolic aspects of the polycystic ovary syndrome.
Randeva HS; Tan BK; Weickert MO; Lois K; Nestler JE; Sattar N; Lehnert H
Endocr Rev; 2012 Oct; 33(5):812-41. PubMed ID: 22829562
[TBL] [Abstract][Full Text] [Related]
34. Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome.
Moro C; Pasarica M; Elkind-Hirsch K; Redman LM
J Clin Endocrinol Metab; 2009 Jul; 94(7):2579-86. PubMed ID: 19366845
[TBL] [Abstract][Full Text] [Related]
35. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity.
Mather KJ; Kwan F; Corenblum B
Fertil Steril; 2000 Jan; 73(1):150-6. PubMed ID: 10632431
[TBL] [Abstract][Full Text] [Related]
36. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X
Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599
[TBL] [Abstract][Full Text] [Related]
37. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
38. Metabolomics and correlation network analysis of follicular fluid reveals associations between l-tryptophan, l-tyrosine and polycystic ovary syndrome.
Hou E; Zhao Y; Hang J; Qiao J
Biomed Chromatogr; 2021 Mar; 35(3):e4993. PubMed ID: 32986877
[TBL] [Abstract][Full Text] [Related]
39. Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome.
Baillargeon JP; Iuorno MJ; Apridonidze T; Nestler JE
Metab Syndr Relat Disord; 2010 Apr; 8(2):127-36. PubMed ID: 20156067
[TBL] [Abstract][Full Text] [Related]
40. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.
Alpañés M; Luque-Ramírez M; Martínez-García MÁ; Fernández-Durán E; Álvarez-Blasco F; Escobar-Morreale HF
Fertil Steril; 2015 Mar; 103(3):795-801.e2. PubMed ID: 25585504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
